Maximize the Clinical Translation of Macrophage Therapies to Deliver Safe and Efficacious Treatment for Oncology, Autoimmunity, Inflammation and Beyond
The annual Macrophage-directed Therapies Summit returned as the leading industry focused summit dedicated to delivering clinical proof of concept through the effective translation of macrophage-directed therapies whilst ensuring safety, control and effective combination strategies.
Across 3 days of carefully curated sessions, we gathered over 100 of the leading c-level executives and KOLs in macrophage clinical development from the likes of CARISMA therapeutics, Merck, Arch Oncology, Pionyr and Trillium to change the foundation of treatment by modulating the behavior and function of macrophage therapies.
In 2021, there were 2 tracks of cutting-edge content from targeting “do not eat me” signals and beyond, to engineered macrophage therapies and interleukin directed approaches to ensure safety, reduce toxicity, manage, and control the plasticity of macrophages.
You can’t afford to miss the annual Macrophage-directed Therapies Summit as we bring you more speakers, more content and more exclusive insights than ever before!
Expert Speakers Include
Head Myeloid Cell Research, Translational Innovation Platform Oncology & Immuno- Oncology
Co-Founder & VP, Discovery